Nicholas Opalich

Nicholas Opalich, hailing from Northeast Ohio, is a distinguished executive and consultant with over 25 years of in-depth experience in the pharmaceutical industry. His expertise notably includes high-level roles in hospice pharmaceutical claims processing, the pharmacy benefits sector, and drug manufacturing. He has earned a reputation for his extensive knowledge in hospice and palliative care pharmacy operations, as well as in mail-order pharmacy systems, specialty infusion services, and pharmaceutical procurement. At the National Hospice and Palliative Care Organization (NHPCO), Opalich has been appointed the Founder & CEO of HospiceChoice Rx. Visit www.nhpco.org for further information. Nick's journey in the pharmaceutical landscape has seen him excel in executive positions, where he was pivotal in guiding companies through various aspects of business development, account management, and product design management. Notably, his leadership has been instrumental in achieving significant company valuations. Opalich is an alumnus of David N. Myers University in Cleveland, Ohio, where he attained bachelor's degrees in both pharmacy and business management. Beyond his professional endeavors, he is committed to philanthropy and volunteering, supporting causes related to animal welfare, poverty alleviation, public health, and homeless shelter services. His interests include family, football, sailing, and wrestling. In his current role, he is the Founder and CEO of HospiceChoice Rx, a pharmacy benefit manager specializing in hospice care, which began its operations in 2023. Under his leadership, HospiceChoice Rx is concentrating on forming partnerships with significant hospice providers, emphasizing cost-effective pharmacy benefit administration while prioritizing patient care and comfort. Previously, Nicholas established and led Outpatient Physician Services of America, Inc. (OPSIA) and its counterpart in Cleveland (OPSIC). His tenure as COO at OPSIC and CEO at OPSIA was marked by significant growth and adaptation to the changing regulatory environment. After the acquisition of OPSIC by OPSIA, the organization was rebranded as Continental Healthcare, Inc. (CHC), becoming a significant player in organ and bone marrow transplant distribution and pharmacy services. In 2002, Nick Opalich founded Strategica Health Partners in Cleveland, a consultancy specializing in healthcare services and pharmaceutical solutions. During his leadership, the firm became a notable independent distributor and medical model developer. His role at Strategica involved contracting, drug procurement, pharmacy relations, and guiding clients through stages of development and growth. He completed his CEO tenure at Strategica Health Partners in 2013, continuing as a managing partner.